Immunovia - Discover and develop tools for early diagnosis of cancers

“Pancreatic cancer is one of the most aggressive and difficult cancers to diagnose. When detected at an early stage, 5-year survival rates are greatly improved; however, currently, most diagnosed cases are in late stages. It is for this and other reasons that a test for early detection is critical. Immunovia’s IMMray™ PanCan-d has the potential of being such tool, and we are looking forward to be part of this large validation study to reveal its clinical value.”
Dr. Randall Brand, Director, GI Malignancy Early Detection, Diagnosis and Prevention Program at University of Pittsburgh.

49 min

Financial reports

November 2020

Immunovia AB published the company’s Interim Report January-September 2020 on Thursday, November 12, 2020, at 16.00 p.m. CET.

Financial reports


16-19 December, 2020
25th conference of WONCA Europe – Virtual event
Place: Berlin, Germany
20 January-19 February 2021
Online Interdisciplinary Congress 2021 on Quality of Cancer Care
Place: Online German event
17 February, 2021
Financial Statement 2020
Place: Immunovia website
All events

Subscribe to receive press releases and reports via email
To start your subscription you need to activate your e-mail address by clicking the link in the email that is sent to you after you have submitted this form. Please check the junk mail if you cannot find the message.

Press releases
Financial reports